stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. BDX
    stockgist
    HomeTop MoversCompaniesConcepts
    BDX logo

    Becton, Dickinson and Company

    BDX
    NYSE
    Healthcare
    Medical - Instruments & Supplies
    Franklin Lakes, NJ, US70,000 employeesbd.com
    $154.72
    -1.61(-1.03%)

    Mkt Cap $56.1B

    $102.07
    $185.39

    52-Week Range

    At a Glance

    AI-generated

    Revenue breakdown: Life Sciences (50.9%), Interventional (49.1%).

    8-K
    BD furnished recast historical financial information to reflect its Biosciences and Diagnostic Solutions business as discontinued operations following the February 9, 2026 spin-off and combination with Waters Corporation.

    $56.1B

    Market Cap

    $27.9B

    Revenue

    $2.2B

    Net Income

    Employees70,000
    Fundamentals

    How The Business Makes Money

    Revenue by Segment

    Life Sciences50.9%($62.0B)
    Interventional49.1%($59.7B)

    Revenue by Geography

    US50.8%($106.7B)
    Non Us36.9%($77.6B)
    EMEA6.4%($13.4B)
    Asia4.2%($8.9B)
    Others Country1.7%($3.5B)
    Activity

    What Changed Recently

    Management Change
    Jan 29, 2026

    . Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Executive O

    Financial Results
    Apr 1, 2026

    RESULTS OF OPERATIONS AND FINANCIAL CONDITION. As previously disclosed, on February 9, 2026, Becton, Dickinson and Company (“BD”) completed the spin-off of its

    Financial Results
    Feb 8, 2026

    RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On February 9, 2026, Becton, Dickinson and Company (“BD”) issued a press release announcing its financial results

    Securities Issuance
    Feb 4, 2026

    Unregistered Sales of Equity Securities. The information set forth in Item 5.03 below is incorporated herein by reference. The Preferred Shares (defined below)

    Other Event
    Feb 24, 2026

    . Other Events On February 25, 2026, Becton, Dickinson and Company (the “Company”) announced the early tender results for its previously announced tender offers

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    CAHCardinal Health, Inc.$214.03+0.95%$50.4B29.2
    EWEdwards Lifesciences Corp...$80.85-0.50%$47.0B44.5
    ARGXargenx SE$745.24+0.28%$46.1B37.1
    IDXXIDEXX Laboratories, Inc.$570.15+0.97%$45.4B43.7
    HLNHaleon plc$9.95-0.25%$44.3B21.8
    ALCAlcon Inc.$74.49-1.35%$36.3B37.0
    RMDResMed Inc.$224.28+0.64%$32.7B22.5
    AAgilent Technologies, Inc...$115.40+0.75%$32.6B24.6
    Analyst View
    Company Profile
    CIK0000010795
    ISINUS0758871091
    CUSIP075887109
    Phone201 847 6800
    Address1 Becton Drive, Franklin Lakes, NJ, 07417-1880, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice